Alchemab Therapeutics Ltd Patent Application Trends in 2024

Alchemab Therapeutics Ltd patent applications in 2024

Top 10 Technology Areas

• C07K16/22 (PEPTIDES (peptides in foodstuffs)
  • Count: 1 patents
  • Example: 20240228604. ANTI-UNC5C ANTIBODIES simplified abstract (Alchemab Therapeutics Ltd)
• A61P25/28 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS)
  • Count: 1 patents
  • Example: 20240228604. ANTI-UNC5C ANTIBODIES simplified abstract (Alchemab Therapeutics Ltd)
• A61K2039/505 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
  • Count: 1 patents
  • Example: 20240228604. ANTI-UNC5C ANTIBODIES simplified abstract (Alchemab Therapeutics Ltd)
• C07K2317/565 (PEPTIDES (peptides in foodstuffs)
  • Count: 1 patents
  • Example: 20240228604. ANTI-UNC5C ANTIBODIES simplified abstract (Alchemab Therapeutics Ltd)
• C07K2317/567 (PEPTIDES (peptides in foodstuffs)
  • Count: 1 patents
  • Example: 20240228604. ANTI-UNC5C ANTIBODIES simplified abstract (Alchemab Therapeutics Ltd)
• C07K2317/73 (PEPTIDES (peptides in foodstuffs)
  • Count: 1 patents
  • Example: 20240228604. ANTI-UNC5C ANTIBODIES simplified abstract (Alchemab Therapeutics Ltd)
• G16B15/30 (BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY)
  • Count: 1 patents
  • Example: 20240203523. ENGINEERING OF ANTIGEN-BINDING PROTEINS simplified abstract (Alchemab Therapeutics Ltd)
• G06N3/044 (Recurrent networks, e.g. Hopfield networks)
  • Count: 1 patents
  • Example: 20240203523. ENGINEERING OF ANTIGEN-BINDING PROTEINS simplified abstract (Alchemab Therapeutics Ltd)
• G16B30/00 (ICT specially adapted for sequence analysis involving nucleotides or amino acids)
  • Count: 1 patents
  • Example: 20240203523. ENGINEERING OF ANTIGEN-BINDING PROTEINS simplified abstract (Alchemab Therapeutics Ltd)
• G16B40/20 (BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY)
  • Count: 1 patents
  • Example: 20240203523. ENGINEERING OF ANTIGEN-BINDING PROTEINS simplified abstract (Alchemab Therapeutics Ltd)

Emerging Technology Areas

• G16B40/20 (BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY)
  • Count: 1 patents
  • Example: 20240203523. ENGINEERING OF ANTIGEN-BINDING PROTEINS simplified abstract (Alchemab Therapeutics Ltd)
• G16B30/00 (ICT specially adapted for sequence analysis involving nucleotides or amino acids)
  • Count: 1 patents
  • Example: 20240203523. ENGINEERING OF ANTIGEN-BINDING PROTEINS simplified abstract (Alchemab Therapeutics Ltd)
• G06N3/044 (Recurrent networks, e.g. Hopfield networks)
  • Count: 1 patents
  • Example: 20240203523. ENGINEERING OF ANTIGEN-BINDING PROTEINS simplified abstract (Alchemab Therapeutics Ltd)
• G16B15/30 (BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY)
  • Count: 1 patents
  • Example: 20240203523. ENGINEERING OF ANTIGEN-BINDING PROTEINS simplified abstract (Alchemab Therapeutics Ltd)
• C07K2317/73 (PEPTIDES (peptides in foodstuffs)
  • Count: 1 patents
  • Example: 20240228604. ANTI-UNC5C ANTIBODIES simplified abstract (Alchemab Therapeutics Ltd)
• C07K2317/567 (PEPTIDES (peptides in foodstuffs)
  • Count: 1 patents
  • Example: 20240228604. ANTI-UNC5C ANTIBODIES simplified abstract (Alchemab Therapeutics Ltd)
• C07K2317/565 (PEPTIDES (peptides in foodstuffs)
  • Count: 1 patents
  • Example: 20240228604. ANTI-UNC5C ANTIBODIES simplified abstract (Alchemab Therapeutics Ltd)
• A61K2039/505 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
  • Count: 1 patents
  • Example: 20240228604. ANTI-UNC5C ANTIBODIES simplified abstract (Alchemab Therapeutics Ltd)
• A61P25/28 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS)
  • Count: 1 patents
  • Example: 20240228604. ANTI-UNC5C ANTIBODIES simplified abstract (Alchemab Therapeutics Ltd)
• C07K16/22 (PEPTIDES (peptides in foodstuffs)
  • Count: 1 patents
  • Example: 20240228604. ANTI-UNC5C ANTIBODIES simplified abstract (Alchemab Therapeutics Ltd)

Top Inventors

• Iosif Pediaditakis of Brookline MA (US) (1 patent)
• Michelle Sidor of Boston MA (US) (1 patent)
• James McCarthy (1 patent)
• Sandrine Legg (1 patent)
• Giles Lewis (1 patent)
• Laura Sophie Mitchell (1 patent)
• Justin Barton (1 patent)
• Emma Jenkins (1 patent)
• Ralph Raymond Minter (1 patent)
• Donna Finch (1 patent)

Patent Categories

Geographical Distribution of Inventors

Geographical Distribution of US Inventors